Regeneron Reports Fourth Quarter and Full Year 2018 Financial and Operating Results

Wednesday, February 6, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

TABLE 5

REGENERON PHARMACEUTICALS, INC.

NET PRODUCT SALES OF REGENERON-DISCOVERED PRODUCTS (Unaudited)

(In millions)

Three Months EndedDecember 31,

2018

2017

U.S.

ROW

Total

U.S.

ROW

Total

EYLEA*

$

1,078.9

$

724.4

$

1,803.3

$

974.8

$

636.9

$

1,611.7

Libtayo

14.8

14.8

ARCALYST

2.7

2.7

4.0

4.0

Net product sales recorded by

     Regeneron

$

1,096.4

$

978.8

Net product sales recorded by Sanofi*:

Dupixent

$

258.6

$

60.2

$

318.8

$

136.9

$

2.0

$

138.9

Praluent

$

59.7

$

33.5

$

93.2

$

41.6

$

21.7

$

63.3

Kevzara

$

26.6

$

8.6

$

35.2

$

8.2

$

1.3

$

9.5

ZALTRAP

$

2.4

$

25.4

$

27.8

$

3.1

$

22.1

$

25.2

Year EndedDecember 31,

2018

2017

U.S.

ROW

Total

U.S.

ROW

Total

EYLEA*

$

4,076.7

$

2,668.9

$

6,745.6

$

3,701.9

$

2,226.9

$

5,928.8

Libtayo

14.8

14.8

ARCALYST

14.7

14.7

16.6

16.6

Net product sales recorded by

     Regeneron

$

4,106.2

$

3,718.5

Net product sales recorded by Sanofi*:

Dupixent

$

776.3

$

145.7

$

922.0

$

253.8

$

2.7

$

256.5

Praluent

$

181.3

$

125.5

$

306.8

$

131.4

$

63.3

$

194.7

Kevzara

$

74.7

$

21.9

$

96.6

$

11.6

$

1.7

$

13.3

ZALTRAP

$

9.0

$

98.8

$

107.8

$

10.7

$

73.1

$

83.8

* Bayer records net product sales of EYLEA outside the United States and Sanofi records global net product sales

of Dupixent, Praluent, Kevzara, and ZALTRAP.  Refer to Table 4 for the Company's share of profits/losses recorded

in connection with sales of EYLEA outside the United States and global sales of Dupixent, Praluent, and Kevzara. 

Sanofi pays the Company a percentage of aggregate net sales of ZALTRAP.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store